Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the ...
One of the world’s top vaccine-makers is partnering with a major AI company to advance medicine — and its chief executive is excited. Moderna and OpenAI announced an ongoing partnership ...
Pfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022, seeking to revoke patents held ...
After reviewing all available studies related to 19 potential harms of the COVID-19 vaccines, researchers found only one adverse event with a proven link to the Pfizer and Moderna shots ...
opens new tab in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines. GSK said in ...
A Victorian coroner is investigating whether a young woman's death from heart inflammation after receiving her third Covid-19 jab was caused by the Moderna vaccine. Moderna's lawyers appeared ...
Recently, Africa received disenchanting news about Moderna's decision ... efforts to create vaccine production capabilities in Africa. It was pledged after the Covid-19 pandemic raised concerns ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. US biotech Moderna has put plans to build a vaccine plant in Kenya on hold, in a sign that moves to invest ...
Shortly after winning a stay on a COVID-19 vaccine patent lawsuit brought by Moderna, Pfizer and its German partner BioNTech are being dragged into another round of mRNA litigation by GSK.
“Potentially, this is much broader than Covid vaccines or vaccines in general.” The patent that Moderna filed in 2011 relates to how mRNA can be tweaked to reduce the immune response when it ...